Understanding factors contributing to individual differences in opioid addiction vulnerability is essential for developing more effective preventions and treatments. Sensation seeking has been implicated in addiction to several drugs of abuse, yet its relationship with individual differences in opioid addiction vulnerability has not been well established. The primary goal of this study was to evaluate the relationship between locomotor activity in a novel environment, a preclinical model of sensation-seeking, and individual differences in acquisition of i.v. morphine self-administration (SA) in rats. A secondary goal was to evaluate the relationship between activity and elasticity of demand (reinforcing efficacy) for morphine measured using a behavioral economic approach. Following an initial locomotor activity screen, animals were allowed to acquire morphine SA at a unit dose of 0.5 mg/kg/infusion in 4 hour/day sessions (Experiment 1) or 0.2 mg/kg/infusion in 2 hour/day sessions (Experiment 2) until infusion rates were stable. Unit price was subsequently manipulated via progressive reductions in unit dose (Experiment 1) or increases in response requirement per infusion (Experiment 2). Activity levels were not correlated with acquisition of morphine SA in either experiment. Morphine consumption was generally well described by an exponential demand function in both experiments (R 2 values > 0.95 for rats as a group), but activity did not correlate with behavioral economic measures. Locomotor activity in a novel environment did not predict individual differences in acquisition of morphine SA. These data complement findings from some human studies and suggest that the role of sensation seeking in individual differences in opioid addiction vulnerability may be limited.
Introduction
Opioid addiction poses a tremendous burden on public health (Center for Behavioral Health Statistics and Quality, 2013; Center for Behavioral Health Statistics and Quality, 2015) . Although many people experiment with opioids, only a minority undergo the loss of control over drug use that defines addiction (American Psychiatric Association, 2013; Belin et al., 2016) . Understanding the behavioral and neurobiological mechanisms contributing to individual differences in opioid addiction vulnerability is essential for developing more effective preventions and treatments.
Sensation-seeking, or the pursuit of novel and intense experiences and a willingness to take risks in order to attain such experiences (Zuckerman, 1994) , has been implicated in vulnerability to addiction to a variety of drugs including stimulants (e.g. cocaine, amphetamine) and alcohol (Bardo et al., 2013; Belin et al., 2016; Hittner and Swickert, 2006; Piazza et al., 1989) . However, the relationship between sensation-seeking and opioid addiction vulnerability has not been well established. Some studies have shown a positive relationship between sensation-seeking and opioid use in humans (Franques et al., 2003; Kosten et al., 1994; Vest et al., 2016) , while others have shown either no relationship (Conrod et al., 2000; Marino et al., 2013; Nielsen et al., 2012) or a negative relationship (Ahn and Vassileva, 2016) . The reasons for these discrepancies across studies are unclear, but may reflect differences in subject characteristics (e.g., age, sex, drug use history, and/or comorbidities), measure(s) of sensation-seeking, or other factors (Marino et al., 2013) .
Animal models allow for greater experimental control than human studies, and could be useful for understanding the role of sensationseeking in opioid addiction vulnerability. Spontaneous locomotor activity in a novel environment is a commonly used preclinical model of sensation-seeking (Blanchard et al., 2009; Pawlak et al., 2008; Piazza et al., 1989) . Consistent with the relationship between sensation seeking and stimulant use in humans, higher activity reliably predicts greater self-administration (SA) of stimulants (e.g., cocaine, amphetamine), particularly in terms of acquisition (Belin et al., 2008; Belin et al., 2011; Belin and Deroche-Gamonet, 2012; Piazza et al., 1989; Piazza et al., 2000) .
Only limited data are available regarding the relationship between spontaneous locomotor activity and individual vulnerability in i.v. opioid SA. In a comparison between several inbred rat strains, those strains with higher activity levels also exhibited greater acquisition of morphine SA under certain conditions (Ambrosio et al., 1995;  see Discussion for further details). However, the relationship between locomotor activity and opioid SA in outbred rodents has not been evaluated. This represents an important research gap given that inbred and outbred rats are genetically distinct, and because findings on predictors of addiction vulnerability in inbred and outbred rat strains are not always concordant (Cadoni et al., 2015; Chaouloff et al., 1995; Dilleen et al., 2012; Meyer et al., 2010) .
The primary goal of this study was to evaluate locomotor activity as a predictor of individual differences in the acquisition of morphine SA in outbred rats. Because activity did not predict acquisition of morphine SA under the conditions initially studied (0.5 mg/kg/infusion, 4 h/day sessions), we evaluated the generality of this finding to a different model with a lower dose and shorter access period (0.2 mg/kg/infusion, 2 h/day sessions). This approach was used because the relationship between activity and SA of other drugs (e.g. cocaine) can be more apparent when lower unit doses and/or shorter access periods are used (Belin et al., 2016; Kabbaj, 2006; Mantsch et al., 2001) .
A secondary goal was to apply a behavioral economics framework to the analysis of individual differences in morphine SA. Behavioral economics involves evaluation of the extent to which consumption of a reinforcer (e.g., drug) is maintained following increases in its unit price, which in drug SA models is operationalized as the cost-benefit ratio of response requirement/unit dose (Bickel et al., 2000; Hursh, 1991; Hursh and Silberberg, 2008) . Behavioral economics has been useful for studying individual differences in elasticity of demand (i.e., reinforcing efficacy) of numerous addictive drugs (e.g., cocaine) in both humans and animals (Diergaarde et al., 2008; Grebenstein et al., 2013; Hursh and Silberberg, 2008; LeSage et al., 2016 ), but has not yet been applied to morphine SA in rodents. Therefore, we evaluated elasticity of demand in animals that acquired morphine SA in both experiments in order to 1) evaluate the precision and generalizability of a behavioral economic framework in the context of morphine SA, and 2) provide a preliminary evaluation of the relationship between locomotor activity and individual differences in behavioral economic measures.
Materials and methods

Animals
Male adult Sprague Dawley rats (Envigo, Indianapolis, IN) weighing 276-300 g at arrival were used. All rats were individually housed in a temperature-and humidity-controlled colony room with unlimited access to water under a reversed 12-h light/dark cycle (lights off at 10:00 h). All behavioral testing occurred during the dark (active) phase. Beginning one week following arrival, food was restricted to 18 g/day to facilitate operant performance, avoid detrimental health effects of long-term ad libitum feeding, and limit catheter migration. Chambers were placed inside sound-attenuating cubicles equipped with exhaust fans that provided masking noise and ambient lighting. Openfield activity software (Med Associates) was used for operating the apparatus and recording data.
Morphine self-administration
Self-administration (SA) sessions were conducted using 16 standard operant conditioning chambers (model ENV-007, Med Associates, Inc). Each chamber contained two response levers, a white stimulus light located 2 cm above each lever, and a house light that provided ambient illumination. Each chamber was placed inside a sound-attenuating cubicle equipped with an exhaust fan that provided masking noise. An infusion pump (model PHM-100-15, Med Associates) placed outside each cubicle delivered infusions at a rate of 100 μl/kg per second. MED-PC IV software (Med Associates) was used for operating the apparatus and recording data.
Drugs
Morphine sulfate (NIH National Institute on Drug Abuse Drug Supply Program, Bethesda, MD) was dissolved in sterile saline and heparin (30 units/ml) was added to maintain catheter patency. Morphine doses are expressed as the weight of the salt.
Surgical procedures
Each rat was implanted with a chronic indwelling catheter into the right jugular vein under isoflurane (1%-3%) anesthesia, using general surgical procedures described in detail elsewhere (Harris et al., 2008; LeSage et al., 2002) . The catheter was externalized between the scapulae and attached to a vascular-access harness (VAH95AB, Instech Laboratories, Plymouth Meeting, PA) that allowed connection to a fluid swivel via a tether for morphine administration. Animals were allowed to recover for one week after surgery, during which time they received daily i.v. infusions of heparinized saline, ceftriaxone antibiotic (5.25 mg, first three days only), and s.c. injections of buprenorphine (0.05 mg/kg; first two days only) for analgesia. Infusions of methohexital (0.1 ml, 10 mg/ml, i.v.) were administered to check patency post-session on Fridays throughout all protocols. If a catheter became occluded (indicated by a failure of the animal to exhibit anesthesia within 3-5 s after methohexital infusion), another catheter was implanted into the ipsilateral femoral vein. Failure of this second catheter resulted in removal of the animal from the study. Six days after arrival, rats (N = 16) were monitored for locomotor activity in a novel open field for 2 h. At least 24 h later, rats were catheterized as described above. After a 7-10-day recovery period, rats were allowed to acquire i.v. morphine SA during daily 4 h sessions conducted Mon-Fri. During each session, responding on the left ("active") response lever resulted in an i.v. infusion of morphine sulfate at a unit dose (0.5 mg/kg/infusion) that maintains robust SA and that has previously been used to evaluate other determinants (e.g., pain sensitivity) of individual differences in morphine SA (Park et al., 2017; Nishida et al., 2016) . Each infusion was accompanied by offset of the house light and the onset of a white cue light above the active response lever. Following a 5-second timeout period, the cue light above the active lever was extinguished to signal availability of the next infusion. Responses on the other lever in the operant chamber (the "inactive" lever) were recorded but had no programmed consequences. On the first day of acquisition (always a Friday), food powder was placed on the active lever to facilitate contact with the lever. Data from this session were not included in the data analysis. Beginning the following Monday, rats were tested under an FR 1 schedule for at least 10 sessions and until acquisition criteria were met (≥5 infusions per session, ≤20% coefficient of variation, and ≥2:1 response ratio on the active to inactive lever) across 3 sessions, at which point the FR was increased to FR 2 for at least 5 sessions and then to FR 3. We used a FR 3 schedule prior to unit dose manipulation in order to be consistent with previous studies evaluating elasticity of demand for other drugs (e.g., nicotine) in our lab (Grebenstein et al., 2013; Grebenstein et al., 2015; Raleigh et al., 2014) . When infusion rates were stable under the FR 3 schedule (same stability criteria as above), unit price was manipulated by progressively reducing the morphine unit dose according to the following progression: 0.3, 0.1, 0.05, 0.025, 0 mg/kg. Each unit dose was tested for 5 sessions. Four rats exhibited self-mutilation and were tested under an accelerated schedule in order to expedite the protocol. These animals were tested in 1-3 sessions per unit dose at either 1 (n = 3) or 2 (n = 1) of the 6 unit doses. All of these animals completed the standard 5 sessions per unit dose for the remaining unit doses. Data for these 4 animals did not impact our overall conclusions and are included in the analyses below.
Experiment 2
Rats (N = 22) were tested for locomotor activity as described in Experiment 1, catheterized, and allowed to acquire i.v. morphine SA at a unit dose of 0.2 mg/kg/infusion (n = 16) or 0 mg/kg/infusion (saline) (n = 6) in 2 hour/day sessions under a FR 1 schedule for at least 10 sessions. A longer timeout period following each infusion (30 s rather than 5 s) was used in an attempt to avoid the self-mutilation observed in Experiment 1. No mutilation was observed at any point in this experiment. In animals exhibiting stable SA at FR 1 (same criteria as above), the FR was increased every 5 sessions according to the following progression: FR 2, 3, 6, 12, 24, etc., until infusion rates declined by at least 90% compared to FR1. Unit price was manipulated via increases in FR requirement rather than decreases in unit dose for two reasons. First, based on data from Experiment 1, it was unclear whether a dose-reduction protocol using a 0.2 mg/kg/infusion training dose would provide a sufficient number and range of unit prices for a behavioral economic analysis (see Fig. 1D ). This approach also allowed us to evaluate the precision of the exponential demand function for describing morphine consumption when unit price was manipulated in this manner. In theory, increasing unit price via dose reduction or FR escalation should produce functionally equivalent effects on consumption (Bickel et al., 1995; Greenwald and Hursh, 2006 ).
Statistical analyses
All statistical analyses and graphing were performed either in GraphPad Prism 7 or R (ver. 3.2.3). Locomotor activity was measured as total distance traveled (in cm) during the 2-hour activity test and was analyzed using one-way ANOVA. Secondary measures of activity included ambulatory count (horizontal photobeam breaks), stereotypic count (repetitive horizontal photobeam breaks) and vertical count (vertical photobeam breaks). In general, lever presses or infusions during morphine SA were analyzed using ANOVA followed by Sidak's or Dunnet's multiple comparison tests (see Results for more details). The primary measure of morphine SA acquisition was the mean number of infusions per session during the first 10 days of acquisition. Secondary measures of acquisition were 1) mean number of infusions during the first 10 min of each session during the first 10 days of acquisition, a period that can be especially sensitive for detecting predictors of morphine SA (Nishida et al., 2016) , and 2) number of days to achieve acquisition criteria. Pearson's correlation was used to examine relationships between locomotor activity and measures of morphine SA acquisition and demand (see below). To confirm that collapsing locomotor data across the entire 2 hour locomotor session did not obscure a relationship between early-session activity and morphine SA, these correlational analyses were repeated using locomotor activity during only the first 30 min of the session. Finally, in an additional analysis, measures of morphine SA were compared between subgroups of rats designated as high or low responders based on whether their 2 hour activity level was above or below the median of the sample (see Dellu et al., 1996; Piazza et al., 1989; Piazza et al., 2000) . In both experiments, these high responder versus low responder comparisons yielded the same conclusions as the correlational analyses and are not reported.
To determine elasticity of demand (reinforcing efficacy) during unit dose reduction (Experiment 1) or FR escalation (Experiment 2), exponential demand curve analyses were conducted using the following equation:
In this model, Q is the quantity consumed. The independent variable, C, is the cost of morphine based on the unit price (FR/unit dose). The free parameters, Q 0 and α are estimated from the best-fit function and refer to the maximum level of consumption at zero price (i.e., level or "intensity" of demand) and the rate of change in consumption with increases in unit price, respectively. The range of the exponential function, k is a constant specifying the range of consumption in log units. The k value is held constant across all data sets being compared in each experiment (set to 2.3 in Experiment 1 and 1.8 in Experiment 2), because changes in k impact the value of α. The α parameter is considered a measure of reinforcing efficacy, such that drugs that produce rapidly declining (elastic) demand curves have higher α values and lower reinforcing efficacy than demand curves with slower declining (inelastic) demand curves. Therefore, α served as the index of elasticity of the demand for, or the reinforcing efficacy of morphine. Other demand measures of interest included: Q 0 , the level or intensity of demand as described above; Omax, the maximal response output; and Pmax, the unit price at which maximal response output occurred. Demand functions were generated using a template for GraphPad Prism software provided by the Institutes for Behavior Resources, Inc. (Baltimore, MD) on their website.
Results
Experiment 1
Locomotor activity
One-way ANOVA of locomotor activity in rats that later completed at least 10 days of morphine self-administration (SA) indicated a main effect of time (F(6.939, 104.1) = 43.35, p < 0.0001). Activity levels were highest during the first 30 min of the 2-hour session (Fig. 1A) , consistent with previous literature (e.g., Piazza et al., 1989) .
Acquisition
All data were removed for one rat that pulled out its catheter following 8 acquisition sessions and died during i.v. catheter re-implantation. A two-factor ANOVA on data for the remaining 15 animals indicated a significant main effect of lever (F(1, 14) = 119.2, p < 0.0001), but no main effect of session or interaction during the first 10 acquisition sessions (Fig. 1B) . Sidak's multiple comparisons test further showed significant differences in responding on the active versus inactive levers during all 10 sessions (t = 5.24-6.93, p < 0.0001). Infusion rate did not differ significantly across sessions (Fig. 1C) .
Elasticity of demand
One rat did not complete dose-response testing due to multiple catheter occlusions. Data for this animal have been removed. One-way ANOVA on data for the remaining animals revealed a significant effect of dose on number of infusions (F(1.786, 23.21) = 19.91, p < 0.0001). Post-hoc Dunnett's multiple comparisons test showed that infusions at 0.05, 0.1, 0.3, 0.5 mg/kg/infusion were all significantly higher than at 0 mg/kg/infusion (q = 4.41-6.35, p < 0.0001-0.003), while there was only a marginally significant difference between infusions at 0.025 versus 0 mg/kg/infusion (q = 2.69, p = 0.0686, see Fig. 1D ). Morphine consumption during demand testing was well-described by an exponential demand function, with R 2 values typically ≥0.85 for individual animals and R 2 = 0.97 for rats as a group (Table 1 , Fig. 1E ).
There was a considerable degree of individual variability in α values (i.e., elasticity of demand), with some rats showing a rapid decline in morphine consumption following increases in unit price (i.e., reductions in unit dose) (e.g., rat #14 in Table 1 and Fig. 1E ) and others maintaining significant consumption despite the increases in unit price (e.g., rat #6 in Table 1 and Fig. 1E ).
Correlations
Pearson's correlation indicated that total distance traveled during the 2-hour locomotor test was not correlated with average daily infusion rate during acquisition of morphine self-administration (SA) (r = 0.05, p = 0.86), average infusions during the first 10 min of each session during acquisition (r = −0.21, p = 0.46) ( Fig. 2A-B) , or days to acquire (r = 0.23, p = 0.41) ( Fig. 2C ; n = 15). Moreover, distance traveled during locomotor testing did not predict elasticity of demand (reinforcing efficacy) (r = −0.11, p = 0.70) (Fig. 2D) , intensity of demand (maximum consumption at zero price) (r = 0.10, p = 0.73) (Fig. 2E) , Pmax (r = 0.14, p = 0.63), or Omax (r = 0.18, p = 0.55) (data not shown graphically; n = 14). Consistent with the above analyses, activity during the first 30 min of the 2 hour locomotor test was not correlated with average daily infusion rate during acquisition (r = 0.31, p = 0.26) or any other measure of morphine SA (data not shown). Secondary activity measures including ambulatory count (mean ± SEM = 2027.7 ± 181.1), stereotypic count (12,403.3 ± 702.1), and vertical count (208.7 ± 21.5) were not significantly correlated with average daily infusion during acquisition or other measures of morphine SA (all p ≥ 0.33) (data not shown).
Experiment 2 3.2.1. Locomotor activity
As in Experiment 1, one-way ANOVA of locomotor activity indicated a main effect of time (F(7.058, 105.9) = 69.27, p < 0.0001), with most activity occurring during the first 30 min of the 2-hour session (Fig. 3A) .
Acquisition
A three-factor ANOVA (lever x drug x session) indicated significant main effects of lever (active vs inactive) (F(1, 20) = 10.70, p = 0.004) and drug (morphine vs. saline) (F(1, 20) = 10.25, p = 0.004), and a significant lever x drug interaction (F(1, 20) = 5.14, p = 0.035). There was no main effect of session or other interactions. A two-factor ANOVA on data for the morphine group indicated a significant effect of lever (F(1, 15) = 22.16, p = 0.0003), but no effect of session or interaction (Fig. 3B ). Sidak's multiple comparisons test further showed significant differences in responding on the active versus inactive levers during all 10 sessions 
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Pharmacology, Biochemistry and Behavior 166 (2018) [48] [49] [50] [51] [52] [53] [54] [55] [56] (t = 3.33-6.46, p < 0.01). Analysis of active and inactive lever data for rats in the saline group indicated no effect of lever, session, or interaction. Analysis of infusion rates indicated a significant effect of drug (F(1, 20) = 11.36, p = 0.0030), but no effect or session or interaction (Fig. 3C) .
Elasticity of demand
None of the animals in the saline group were tested for demand because none of them achieved SA acquisition criteria. Eight of the 16 animals in the morphine group did not complete this phase due to failure to acquire, loss of catheter patency, or other problem. One-way repeated measures ANOVA on data from the 8 remaining animals revealed significant effect of FR on number of morphine infusions (F (1.941, 15.53) = 21.29, p < 0.0001). Post-hoc Dunnett's multiple comparisons test showed that infusions at FR 12, 24 and 48 were all significantly lower than at FR 1 (q = 3.94-6.62, p = 0.02-0.0007). Infusions at FR 6 only marginally differed from infusions at FR 1 (q = 3.00, p = 0.07) (Fig. 3D) .
Morphine consumption during demand testing was generally welldescribed by an exponential demand function (R 2 = 0.96 for rats as a group, Fig. 3E ), with considerable individual variability in α values (Table 1) .
Correlations
Distance traveled during the 2-hour locomotor test was not correlated with average daily infusion rate during acquisition of morphine SA (r = 0.06, p = 0.82, n = 16), average infusions during the first 10 min of each session (r = −0.16, p = 0.56, n = 16) ( Fig. 4A-B) , or days to acquire (r = −0.11, p = 0.73, n = 13) (Fig. 4C) . Moreover, distance traveled did not predict elasticity of demand (r = −0.21, p = 0.62) (Fig. 4D) , intensity of demand (r = −0.13, p = 0.77) (Fig. 4E) , Pmax (r = 0.30, p = 0.47), or Omax (r = 0.20, p = 0.64) (data not shown graphically; n = 8 for all behavioral economic measures). Activity during the first 30 min of the 2 hour locomotor session also was not correlated with average daily infusion rate during acquisition (r = 0.002, p = 0.99) or any other measures of morphine SA (data not shown). Other measures including ambulatory count (mean ± SEM = 2640.9 ± 177.5), stereotypic count (14,046.4 ± 755.6) and vertical count (228.3 ± 15.7) were not correlated with average daily infusion during acquisition or other measures of morphine SA (all p ≥ 0.25) (data not shown). Fig. 2 . Relationship between distance traveled during the 2 hour locomotor activity test and (A) mean daily infusions during the first 10 sessions of acquisition, (B) mean daily infusions during the first 10 min of each session during the first 10 acquisition sessions, (C) number of days to acquire, (D) elasticity of demand (log α) and (E) intensity of demand (Q 0 ). Pharmacology, Biochemistry and Behavior 166 (2018) 48-56 
Discussion
The main finding of this study is that spontaneous locomotor activity did not predict acquisition of morphine self-administration (SA) in rats using two distinct morphine SA protocols.
To the extent that activity in an open field is relevant to sensationseeking, our data are consistent with some human studies indicating a lack of positive relationship between sensation seeking and opioid addiction vulnerability (Ahn and Vassileva, 2016; Marino et al., 2013; Nielsen et al., 2012) . For example, a recent analysis showed that high sensation-seeking and impulsivity are predictors of greater vulnerability to amphetamine addiction but not heroin addiction (Ahn and Vassileva, 2016) . In contrast, other human studies indicate that sensation-seeking is positively associated with opioid addiction vulnerability (Cheng et al., 2015; Franques et al., 2003; Kosten et al., 1994) . Taken together, these data suggest that the relationship between sensationseeking and opioid addiction vulnerability may be complex and may not be observable under all conditions.
Our data with outbred rats contrast with a previous report that inbred rat strains with higher rates of spontaneous locomotor activity also exhibited greater acquisition of morphine SA (Ambrosio et al., 1995) . This discrepancy may reflect genetic differences between outbred and inbred rat strains (Zhou et al., 2008) and/or our use of a within-strain rather than between-strain comparison. In addition, the significant between-strain correlation reported in Ambrosio et al. (1995) was only observed when activity was measured after catheterization. This relationship was lost when activity was measured before catheterization (i.e., catheterization changed the rank order of inbred strains in terms of locomotor activity), which is the approach used in this study and most others evaluating activity/drug SA relationships. These factors, as well as other methodological differences across studies (e.g., unit dose), could account for the difference.
Based on their findings that spontaneous locomotor activity predicted acquisition of both food and cocaine SA, Mitchell and colleagues suggested that locomotor activity predicts a general learning capability for operant lever pressing rather than drug use propensity per se (Mitchell et al., 2005) . Our findings that locomotor activity did not predict acquisition of morphine SA contrasts with this prediction, and suggests that the relationship between activity and SA may be more complex.
Our current extension of behavioral economics to morphine SA further supports the precision, generalizability, and utility of this analytical approach. An exponential demand function described morphine consumption well, consistent with findings using drugs and other reinforcers in animals and humans (Grebenstein et al., 2013; Hursh, 1991; Hursh and Silberberg, 2008) . Importantly, considerable individual differences were observed in α in both studies (Table 1) , supporting the use of this approach to measure individual differences in addiction vulnerability. Evaluation of other factors (e.g., opioid withdrawal sensitivity) as determinants of individual differences in demand for morphine is warranted.
The primary goal of this study was to understand the relationship between locomotor activity and morphine SA rather than direct comparison between the determinants of individual differences in morphine versus stimulant addiction. Nonetheless, our data contrast with findings indicating that activity reliably predicts acquisition of SA and reinforcing efficacy of stimulants (e.g., cocaine, amphetamine, nicotine) Belin et al., 2016; Suto et al., 2001; Turner et al., 2008; Piazza et al., 2000) . They also complement studies that other predictors of stimulant SA (e.g., impulsivity) do not predict individual differences in opioid SA (Ahn and Vassileva, 2016; Dilleen et al., 2012; McNamara et al., 2010) . The cause of these potential differences across drug classes is unclear, but may include differences in their neurobiological effects (e.g. drug-induced synaptic and structural plasticity) or different needs for self-medication (Badiani et al., 2011; Markou et al., 1998) . That is, due to the different psychoactive effects of opioids versus stimulants (e.g., anxiolytic effects versus arousal), individuals with varying psychological characteristics (e.g., degree of sensation-seeking) might prefer one drug class over the other (Khantzian, 1985; Markou et al., 1998) .
Alternatively, the lack of concordance between the current findings and those with other drugs may reflect methodological factors unique to this study (rat strain, equipment, etc.) rather than our use of an opioid instead of other drugs. However, the rat strain, equipment, and general procedure used here were almost identical to that used in several studies reporting positive relationships between activity and acquisition of SA of non-opioids (e.g., Belin et al., 2008; Smith et al., 2015; Suto et al., 2001) . Furthermore, the ability of activity to predict acquisition of SA of other drugs has remained robust despite numerous methodological differences across studies and laboratories including variations in rat strain, method of activity assessment (e.g., circular runway versus open field), operant response (lever press versus nosepoke), etc. Indeed, locomotor activity has been described as the most reliable predictor of drug SA in the preclinical individual differences literature (Bardo et al., 2013; Blanchard et al., 2009 ). Nonetheless, inclusion of a positive control group tested under the same conditions but responding for a stimulant (e.g., cocaine) in future studies is needed to confirm that our findings reflect a true difference in predictors of SA across drugs. Further evaluating the relationship between activity and opioid SA using other unit doses, durations of access, types of opioids, etc., is also needed to confirm the generality of our findings. Understanding the ability of other putative measures of sensation-seeking (e.g., preference for a novel environment) Cain et al., 2005) to predict individual differences in opioid SA is also of interest.
There are several limitations to our study. First, group sizes were relatively small, which may have limited our ability to detect a significant relationship between activity and morphine SA. However, previous studies have detected correlations between locomotor activity and acquisition of stimulant SA using similar or even smaller group sizes (e.g., Mitchell et al., 2005; Smith et al., 2015) . Given the absence of even a trend for activity to predict acquisition measures in either experiment (see Fig. 2 and 4) , it is unlikely that the use of larger group sizes would have changed our conclusions regarding these relationships. An additional limitation is that some rats in Experiment 1 exhibited self-mutilation during dose-response testing, which required testing them for a shorter number of days at 1-2 of the 6 unit doses. However, removal of data for these animals did not change our conclusions. Importantly, this issue was not present during acquisition, which was our primary outcome.
While not a primary goal of this study, our use of open-field activity testing provided the opportunity to examine the relationship between time in the periphery versus center of the activity chamber (i.e., thigmotaxis), a measure of anxiety-like behavior (Cohen et al., 2009; Prut and Belzung, 2003; Treit and Fundytus, 1988) , and individual differences in morphine SA. Anxiety has been linked to opioid addiction vulnerability in humans (Lejuez et al., 2008; Martins et al., 2012; Norton, 2001) , and anxiety-like behavior in the elevated plus maze predicted individual differences in cocaine SA in rodents (Dilleen et al., Y. Swain et al. Pharmacology, Biochemistry and Behavior 166 (2018) [48] [49] [50] [51] [52] [53] [54] [55] [56] 2012; Pelloux et al., 2009; Walker et al., 2009) . We found that thigmotaxis did not predict individual differences in any measure of morphine SA, which is consistent with findings indicating that anxiety-like behavior in the elevated plus maze did not predict individual differences in heroin SA (Dilleen et al., 2012) .
In conclusion, our findings indicate that locomotor activity in a novel environment did not predict individual differences in morphine SA in rats. These data complement findings from some human studies and suggest that the role of sensation-seeking in individual differences in opioid addiction vulnerability may be limited.
